Researcher closes in on drug to reverse Type I diabetes
Research at Massachusetts General Hospital looks increasingly like a long-term cure for type 1 diabetes, with a newly released study showing patients have normal blood sugar levels eight years after a clinical trial.
In research published Thursday in journal npj Vaccines, patients who had been treated with the bacillus Calmette-Guerin (BCG) vaccine — an inexpensive, generic vaccine used around the world to prevent tuberculosis — had normal blood sugar levels eight years after the trial ended.…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Jessica Bartlett Source Type: news
More News: American Health | Clinical Trials | Diabetes | Diabetes Type 1 | Endocrinology | Health Management | Hospitals | Study | Sugar | Tuberculosis | Tuberculosis (BCG) Vaccine | Vaccines